Concepedia

Publication | Open Access

The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes

DOIFull Paper Access

41

Citations

22

References

2018

Year

Eleonora Seelig, James Howlett, Linsey Porter, Lucy Truman, James Heywood, Jane Kennet, Emma L Arbon, Anselmiova Katerina, Neil Walker, Ravinder Atkar,
JCI Insight

Abstract

Sir Jules Thorn Trust, the Swiss National Science Foundation, Wellcome, JDRF, and NIHR Cambridge Biomedical Research Centre.

References

YearCitations

Page 1